Adrenolipoma screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Category |
||
(2 intermediate revisions by one other user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Adrenolipoma}} | {{Adrenolipoma}} | ||
{{CMG}} {{AE}} {{AAM}} | |||
{{CMG}} | |||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine screening for adrenolipoma. | |||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine screening for adrenolipoma. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Endocrine system]] | [[Category:Endocrine system]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Overview complete]] | [[Category:Overview complete]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Endocrinology]] | |||
[[Category:Surgery]] |
Latest revision as of 02:44, 24 October 2017
Adrenolipoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Adrenolipoma screening On the Web |
American Roentgen Ray Society Images of Adrenolipoma screening |
Risk calculators and risk factors for Adrenolipoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Overview
There is insufficient evidence to recommend routine screening for adrenolipoma.
Screening
There is insufficient evidence to recommend routine screening for adrenolipoma.